Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement

BACKGROUND: Base excision repair (BER) pathway is a DNA repair pathway that is important in carcinogenesis and in response to DNA-damaging chemotherapy. XRCC1 is one of important molecular markers for BER. So far, the role of XRCC1 polymorphisms with clinical outcomes of advanced NSCLC treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan-Juan, Xiao, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526237/
https://www.ncbi.nlm.nih.gov/pubmed/28743242
http://dx.doi.org/10.1186/s12885-017-3487-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526237/
https://www.ncbi.nlm.nih.gov/pubmed/28743242
http://dx.doi.org/10.1186/s12885-017-3487-y

Ejemplares similares